CASI PHARMACEUTICALS, INC. (CASIF) Deferred Tax Assets, Valuation Allowance

CASI PHARMACEUTICALS, INC. Deferred Tax Assets, Valuation Allowance

CASI PHARMACEUTICALS, INC. (CASIF) had Deferred Tax Assets, Valuation Allowance of $67.77 million as of 2025-12-31, per its 20-F filed 2026-05-15.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-05-15

• 2025-12-31: Deferred Tax Assets, Valuation Allowance $67.77M.
• 2024-12-31: Deferred Tax Assets, Valuation Allowance $62.47M.
• 2023-12-31: Deferred Tax Assets, Valuation Allowance $61.28M.
• 2022-12-31: Deferred Tax Assets, Valuation Allowance $85.50M.